Similar to our study, recent studies demonstrated that the CLDNs was frequently down-regulated in various cancers, for instance, the expression of CLDN1 was down-regulated in pancreatic cancer cells and that re-expression of CLDN1 reduced the invasive ability of these cells [23, 25]. The gene discussed is CLDN1; the disease is familial pancreatic carcinoma.